Patents by Inventor Saul Silverstein

Saul Silverstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof
    Publication number: 20080279888
    Abstract: The present invention provides genetically engineered cell lines, recombinant vectors, and vaccines. The present invention also provides methods for generating an in vitro system for Varicella zoster virus (VZV), and the in vitro systems generated by these methods. The present invention further provides methods for reactivating VZV, and VZV reactivated by these methods. Finally, the present invention provides a method of screening for an agent for treating VZV infection.
    Type: Application
    Filed: September 24, 2007
    Publication date: November 13, 2008
    Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Michael D. Gershon, Zhenglun Zhu, Saul Silverstein, Anne A. Gershon
  • Genetically engineered cell lines and systems for propagating virus and methods of use thereof
    Patent number: 7273616
    Abstract: The present invention provides genetically engineered cell lines, recombinant vectors, and vaccines. The present invention also provides methods for generating an in vitro system for Varicella zoster virus (VZV), and the in vitro systems generated by these methods. The present invention further provides methods for reactivating VZV, and VZV reactivated by these methods. Finally, the present invention provides a method of screening for an agent for treating VZV infection.
    Type: Grant
    Filed: May 12, 2003
    Date of Patent: September 25, 2007
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Jason J. Chen, Anne A. Gershon, Zhenglun Zhu, Saul Silverstein, Michael D. Gershon
  • Genetically engineered cell lines and systems for propagating Varicella zoster virus and methods of use thereof
    Publication number: 20060121048
    Abstract: The present invention provides genetically engineered cell lines, recombinant vectors, and vaccines. The present invention also provides methods for generating an in vitro system for Varicella zoster virus (VZV), and the in vitro systems generated by these methods. The present invention further provides methods for reactivating VZV, and VZV reactivated by these methods. Finally, the present invention provides a method of screening for an agent for treating VZV infection.
    Type: Application
    Filed: May 12, 2003
    Publication date: June 8, 2006
    Inventors: Jason Chen, Anne Gershon, Zhenglun Zhu, Saul Silverstein, Michael Gershon